INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

$1.0M

Filings

Firms Hired

Active Period

2018–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$90,000	3	1
2025	$120,000	4	1
2024	$120,000	4	1
2023	$120,000	4	1
2022	$80,000	5	1
2021	$175,970	6	1
2020	$103,880	4	1
2019	$98,000	4	1
2018	$109,375	6	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH	$1,017,225	40

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	31
SENATE	26
Health & Human Services, Dept of (HHS)	16
Food & Drug Administration (FDA)	12
Natl Institutes of Health (NIH)	8

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	28
Health Issues	Health Issues	21
Science/Technology	Science/Technology	12
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	3

Bills Explicitly Cited (24)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1082119th Congress

Shandra Eisenga Human Cell and Tissue Product Safety Act

2025 · third_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

HR 1082, Shandra Eisenga Human Cell and Tissue Product Safety Act HR 5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

Client expense: $30,000 · Firm income: —

Matched citations: HR 1082

H.R. 5304119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2025 · third_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

HR 1082, Shandra Eisenga Human Cell and Tissue Product Safety Act HR 5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

Client expense: $30,000 · Firm income: —

Matched citations: HR 5304

H.R. 1082119th Congress

Shandra Eisenga Human Cell and Tissue Product Safety Act

2025 · second_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

HR 1082, Shandra Eisenga Human Cell and Tissue Product Safety Act

Client expense: $30,000 · Firm income: —

Matched citations: HR 1082

H.R. 7188118th Congress

Shandra Eisenga Human Cell and Tissue Product Safety Act

2024 · fourth_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

HR 7188 / S 3733, Shandra Eisenga Human Cell and Tissue Products Safety Act

Client expense: $30,000 · Firm income: —

Matched citations: HR 7188

Show 20 more cited filings

S. 3733118th Congress

Shandra Eisenga Human Cell and Tissue Product Safety Act

2024 · fourth_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

HR 7188 / S 3733, Shandra Eisenga Human Cell and Tissue Products Safety Act

Client expense: $30,000 · Firm income: —

Matched citations: S 3733

H.R. 4758118th Congress

Accelerating Kids’ Access to Care Act

2024 · third_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

HR 7188 / S 3733, Shandra Eisenga Human Cell and Tissue Products Safety Act HR 4758 / S 2372, Accelerating Kids Access to Care Act

Client expense: $30,000 · Firm income: —

Matched citations: HR 4758

H.R. 7188118th Congress

Shandra Eisenga Human Cell and Tissue Product Safety Act

2024 · third_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

HR 7188 / S 3733, Shandra Eisenga Human Cell and Tissue Products Safety Act HR 4758 / S 2372, Accelerating Kids Access to Care Act

Client expense: $30,000 · Firm income: —

Matched citations: HR 7188

S. 2372118th Congress

Accelerating Kids’ Access to Care Act

2024 · third_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

HR 7188 / S 3733, Shandra Eisenga Human Cell and Tissue Products Safety Act HR 4758 / S 2372, Accelerating Kids Access to Care Act

Client expense: $30,000 · Firm income: —

Matched citations: S 2372

S. 3733118th Congress

Shandra Eisenga Human Cell and Tissue Product Safety Act

2024 · third_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

HR 7188 / S 3733, Shandra Eisenga Human Cell and Tissue Products Safety Act HR 4758 / S 2372, Accelerating Kids Access to Care Act

Client expense: $30,000 · Firm income: —

Matched citations: S 3733

H.R. 7188118th Congress

Shandra Eisenga Human Cell and Tissue Product Safety Act

2024 · second_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

HR 7188, Shandra Eisenga Human Cell and Tissue Products Safety Act House FY25 Labor-HHS appropriations bill House FY25 FSGG appropriations bill Senate FY25 FSGG appropriations bill

Client expense: $30,000 · Firm income: —

Matched citations: HR 7188

H.R. 1466118th Congress

Safe RESEARCH Act

2023 · first_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 398, Protecting Life and Integrity in Research Act; H.R. 416, Prohibiting Abortion Industry's Lucrative Loophole Act; H.R. 1466, Safe RESEARCH Act; S. 751, Human-Animal Chimera Prohibition Act; chimeric embryo research; fetal tissue research; validating a test for prion diseases; unproven cellular therapies

Client expense: $30,000 · Firm income: —

Matched citations: H.R. 1466

H.R. 398118th Congress

Protecting Life and Integrity in Research Act of 2023

2023 · first_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 398, Protecting Life and Integrity in Research Act; H.R. 416, Prohibiting Abortion Industry's Lucrative Loophole Act; H.R. 1466, Safe RESEARCH Act; S. 751, Human-Animal Chimera Prohibition Act; chimeric embryo research; fetal tissue research; validating a test for prion diseases; unproven cellular therapies

Client expense: $30,000 · Firm income: —

Matched citations: H.R. 398

H.R. 416118th Congress

Prohibiting Abortion Industry’s Lucrative Loopholes Act

2023 · first_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 398, Protecting Life and Integrity in Research Act; H.R. 416, Prohibiting Abortion Industry's Lucrative Loophole Act; H.R. 1466, Safe RESEARCH Act; S. 751, Human-Animal Chimera Prohibition Act; chimeric embryo research; fetal tissue research; validating a test for prion diseases; unproven cellular therapies

Client expense: $30,000 · Firm income: —

Matched citations: H.R. 416

S. 751118th Congress

Human-Animal Chimera Prohibition Act of 2023

2023 · first_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 398, Protecting Life and Integrity in Research Act; H.R. 416, Prohibiting Abortion Industry's Lucrative Loophole Act; H.R. 1466, Safe RESEARCH Act; S. 751, Human-Animal Chimera Prohibition Act; chimeric embryo research; fetal tissue research; validating a test for prion diseases; unproven cellular therapies

Client expense: $30,000 · Firm income: —

Matched citations: S. 751

H.R. 5247115th Congress

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018

2018 · second_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

Opposition to Right to Try Act S. 204 & H.R. 5247

Client expense: $21,875 · Firm income: —

Matched citations: H.R. 5247

S. 204115th Congress

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017

2018 · second_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

Opposition to Right to Try Act S. 204 & H.R. 5247

Client expense: $21,875 · Firm income: —

Matched citations: S. 204

H.R. 5247115th Congress

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018

2018 · first_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

Opposition to Right to Try Act S. 204 & H.R. 5247

Client expense: $21,875 · Firm income: —

Matched citations: H.R. 5247

S. 204115th Congress

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017

2018 · first_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

Opposition to Right to Try Act S. 204 & H.R. 5247

Client expense: $21,875 · Firm income: —

Matched citations: S. 204

H.R. 5247115th Congress

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018

2018 · first_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

Right to Try Act S. 204 & H.R. 5247; Labor, Health and Human Services, Education and Related Agencies Appropriations Act restriction on fetal tissue research; FDA regulation of stem cell therapies under Section 351 of the Public Health Service Act.

Client expense: — · Firm income: —

Matched citations: H.R. 5247

H.R. 5247115th Congress

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018

2018 · first_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

Right to Try Act S. 204 & H.R. 5247; Labor, Health and Human Services, Education and Related Agencies Appropriations Act restriction on fetal tissue research; FDA regulation of stem cell therapies under Section 351 of the Public Health Service Act.

Client expense: — · Firm income: —

Matched citations: H.R. 5247

H.R. 5247115th Congress

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018

2018 · first_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

Right to Try Act S. 204 & H.R. 5247; Labor, Health and Human Services, Education and Related Agencies Appropriations Act restriction on fetal tissue research; FDA regulation of stem cell therapies under Section 351 of the Public Health Service Act.

Client expense: — · Firm income: —

Matched citations: H.R. 5247

S. 204115th Congress

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017

2018 · first_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

Right to Try Act S. 204 & H.R. 5247; Labor, Health and Human Services, Education and Related Agencies Appropriations Act restriction on fetal tissue research; FDA regulation of stem cell therapies under Section 351 of the Public Health Service Act.

Client expense: — · Firm income: —

Matched citations: S. 204

S. 204115th Congress

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017

2018 · first_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

Right to Try Act S. 204 & H.R. 5247; Labor, Health and Human Services, Education and Related Agencies Appropriations Act restriction on fetal tissue research; FDA regulation of stem cell therapies under Section 351 of the Public Health Service Act.

Client expense: — · Firm income: —

Matched citations: S. 204

S. 204115th Congress

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017

2018 · first_quarter · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text and reported amounts

Right to Try Act S. 204 & H.R. 5247; Labor, Health and Human Services, Education and Related Agencies Appropriations Act restriction on fetal tissue research; FDA regulation of stem cell therapies under Section 351 of the Public Health Service Act.

Client expense: — · Firm income: —

Matched citations: S. 204

Source: Senate LDA

INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH — Lobbying Disclosure | Poliscope